Does Anthem Cover Prolia?
The verdict
Covered on most plans
Anthem (Elevance Health) covers Prolia under the medical benefit with prior authorization across commercial, Medicare Advantage, and Medicaid lines, administered as a q6-month subcutaneous clinic injection and billed under HCPCS J0897 — not dispensed at a pharmacy under Part D. CarelonRx is Anthem's PBM; where the pharmacy benefit applies, specialty routing goes through CarelonRx. As an Elevance BCBS licensee in 14 states, Anthem plans are moving toward Jubbonti biosimilar preference in line with the broader BCBS federation trend. Not covered outside FDA-approved osteoporosis and bone-loss indications.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Anthem using your member ID.
Key facts
Prolia is billed under Medicare Part B (HCPCS J0897) as a clinician-administered injection every 6 months — the $2,100 Part D out-of-pocket cap does not apply to this Part B medical-benefit pathway.
CMS Local Coverage Determination L33394; Medicare.gov
Anthem (Elevance Health) is a BCBS licensee in 14 states with CarelonRx as its PBM; plans are moving toward Jubbonti biosimilar preference consistent with the BCBS federation trend following the Sept. 1, 2025 interchangeable-biosimilar rollout.
Anthem / Elevance Health medical policy; Amgen Jubbonti prescribing information
Prior authorization is required across Anthem lines for Prolia; acceptable documentation includes a DEXA T-score at or below -2.5, a prior fragility fracture, or a high FRAX score.
Anthem medical policy; CMS LCD L33394
Medicare vs. commercial coverage
Whether Anthem covers Prolia depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage: Anthem Medicare Advantage plans cover Prolia under the medical benefit, billed under HCPCS J0897 as a clinician-administered subcutaneous injection every 6 months per Local Coverage Determination L33394. Prior authorization is required with documentation of osteoporosis and high fracture risk. As the Jubbonti (denosumab-bddz) biosimilar rolls out across BCBS licensees, Anthem MA plans are increasingly preferring or requiring Jubbonti before branded Prolia — verify your specific Anthem MA plan. On Original Medicare, members pay 20% coinsurance after the Part B deductible (approximately $357 per injection at average pricing per Medicare.org); a Medigap supplement typically covers this 20%. The $2,100 Medicare Part D out-of-pocket cap does NOT apply to Prolia — it is a Part B medical-benefit drug for most Anthem members, not a Part D pharmacy drug. Verify cost-share on your specific Anthem plan via the Anthem member portal.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: Anthem commercial plans cover Prolia under the medical benefit with prior authorization; documentation of osteoporosis with high fracture risk (T-score at or below -2.5, prior fragility fracture, or elevated FRAX score) is required. CarelonRx manages the pharmacy-benefit pathway where applicable, with growing biosimilar preference toward Jubbonti as an Elevance BCBS licensee. PA approval is typically 12 months; Prolia is clinician-administered q6 months. ACA/Individual: covered with PA where Anthem plans are offered. Medicaid: Anthem-managed Medicaid covers Prolia for osteoporosis with high fracture risk per state preferred drug list; nominal cost-share; PA per state. Verify Anthem-specific cost-share and current biosimilar step-therapy requirements on Anthem's medical-policy lookup at anthem.com.
The 3 boxes you must tick to get approved
Commercial plans that will consider Prolia require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Prolia actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,786–$2,507 per 60 mg dose without insurance (Medicare.org ~$1,786; GoodRx ~$2,507). These are estimates — actual cash price varies by site of care.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial: medical-benefit coinsurance per Anthem plan design — verify on Anthem plan documents. Medicare Advantage: 20% Part B coinsurance after the Part B deductible on Original Medicare (approximately $357 per injection at average pricing; Medigap typically covers this 20%). Anthem MA plan copays vary by plan design — verify on your specific plan. Medicaid: nominal cost-share per state PDL.
Typical monthly copay once prior authorization is approved.
Bridge program
Amgen offers copay support for Prolia for commercially insured patients. This program is NOT available to Medicare or Medicaid beneficiaries under federal anti-kickback rules. Commercially insured Anthem members may be eligible — verify directly with Amgen at amgensupportplus.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates. The Part D $2,100 OOP cap does NOT apply to Prolia on the Part B medical pathway. Verify your specific cost-share with Anthem member services or via the Anthem medical-policy lookup at anthem.com.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Anthem's current denosumab medical policy
Go to anthem.com and search for Anthem's medical policy on denosumab (Prolia). As an Elevance Health BCBS licensee, Anthem publishes plan-specific medical policies governing prior authorization criteria, biosimilar step-therapy requirements, and the Part B billing pathway. The policy is updated as the Jubbonti biosimilar rollout progresses — check the most current version applicable to your state.
- 2
Confirm Prolia is billed under Part B, not Part D
For most Anthem members, Prolia is a medical-benefit (Part B) drug administered in the clinic every 6 months — not a Part D pharmacy drug. Log in to your Anthem member account at anthem.com and verify your plan's benefit structure under the medical benefit section, not the CarelonRx drug formulary. The $2,100 Part D cap does not apply to the Part B pathway.
- 3
Ask your prescriber about the Jubbonti biosimilar and PA submission
As Anthem plans align with the BCBS federation trend, your plan may now prefer or require the Jubbonti (denosumab-bddz) biosimilar before branded Prolia. Confirm with your prescribing physician whether a prior authorization has been submitted under your specific Anthem plan and that any biosimilar step-therapy documentation is current. Bring your DEXA scan results and fracture history to the PA process.
Options if Anthem won't cover Prolia
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Jubbonti (denosumab-bddz)
The interchangeable Prolia biosimilar now preferred on Anthem MA plans and increasingly across BCBS licensees. Same molecule (denosumab), same 60 mg dose, same q6-month subcutaneous injection schedule. FDA-approved interchangeable status means a plan can prefer Jubbonti without a new prescriber decision.
Fosamax (alendronate) — generic
Generic oral bisphosphonate, typically Tier 1 on most formularies. Standard first-line osteoporosis therapy; often considered before Prolia in clinical management, though formal step-therapy-through-bisphosphonate requirements vary by Anthem plan.
Reclast (zoledronic acid)
Annual IV bisphosphonate infusion administered in an office or infusion center, covered under the medical benefit. Appropriate for patients who cannot tolerate oral bisphosphonates; offers similar anti-fracture efficacy.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
For most Anthem members, Prolia is a Part B medical-benefit drug — not a Part D pharmacy pickup. It is administered as a subcutaneous injection in your clinician's office every 6 months and billed under HCPCS J0897, incident to a physician service. This means the $2,100 Medicare Part D out-of-pocket cap does not apply. Your cost is the medical-benefit coinsurance per your Anthem plan design. Verify by checking Anthem's medical policy or your plan documents at anthem.com.
Yes. Anthem requires prior authorization with documentation of osteoporosis and high fracture risk — typically a DEXA scan showing a T-score at or below -2.5, a prior fragility fracture, or a high FRAX score. PA approval is typically 12 months. Anthem is also moving toward step-therapy requirements through the Jubbonti biosimilar on some plans, consistent with the BCBS federation trend. Ask your prescriber to verify current PA criteria for your specific Anthem plan.
CarelonRx is Anthem's (Elevance Health's) pharmacy benefit manager. For most Anthem members, Prolia runs through the medical benefit (Part B buy-and-bill) in the clinic — not the CarelonRx pharmacy formulary. However, if Prolia is ever routed through the pharmacy benefit, CarelonRx manages the formulary and specialty-pharmacy dispensing. Check whether your specific Anthem plan routes denosumab under the medical or pharmacy benefit, as the billing path determines your cost structure and applicable cap.
Anthem plans are increasingly preferring the interchangeable biosimilar Jubbonti (denosumab-bddz) as part of the broader BCBS federation adoption of the denosumab biosimilar. Jubbonti contains the same molecule at the same 60 mg dose on the same q6-month schedule. Whether your specific Anthem plan currently requires Jubbonti first depends on your plan's medical policy — check anthem.com or ask your prescriber. Your treatment protocol does not change; only the product label differs.
No, for most Anthem members. The $2,100 Medicare Part D out-of-pocket cap applies to Part D pharmacy drugs. For most Anthem members, Prolia is a Part B medical-benefit drug billed in the clinic under HCPCS J0897. Part B cost-sharing is governed by your coinsurance structure and supplemental coverage — Medigap typically covers the 20% Part B coinsurance, making out-of-pocket cost $0. Confirm your specific benefit structure with Anthem member services.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Anthem before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.